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The reporting quality of natural language 
processing studies: systematic review of studies 
of radiology reports
Emma M. Davidson1*†, Michael T. C. Poon2,3†, Arlene Casey4, Andreas Grivas4, Daniel Duma4, Hang Dong2,6, 
Víctor Suárez‑Paniagua2,6, Claire Grover5, Richard Tobin5, Heather Whalley1,7, Honghan Wu6,8, 
Beatrice Alex4,9† and William Whiteley1,6,10† 
Abstract 
Background: Automated language analysis of radiology reports using natural language processing (NLP) can 
provide valuable information on patients’ health and disease. With its rapid development, NLP studies should have 
transparent methodology to allow comparison of approaches and reproducibility. This systematic review aims to sum‑
marise the characteristics and reporting quality of studies applying NLP to radiology reports.
Methods: We searched Google Scholar for studies published in English that applied NLP to radiology reports of any 
imaging modality between January 2015 and October 2019. At least two reviewers independently performed screen‑
ing and completed data extraction. We specified 15 criteria relating to data source, datasets, ground truth, outcomes, 
and reproducibility for quality assessment. The primary NLP performance measures were precision, recall and F1 score.
Results: Of the 4,836 records retrieved, we included 164 studies that used NLP on radiology reports. The commonest 
clinical applications of NLP were disease information or classification (28%) and diagnostic surveillance (27.4%). Most 
studies used English radiology reports (86%). Reports from mixed imaging modalities were used in 28% of the studies. 
Oncology (24%) was the most frequent disease area. Most studies had dataset size > 200 (85.4%) but the proportion of 
studies that described their annotated, training, validation, and test set were 67.1%, 63.4%, 45.7%, and 67.7% respec‑
tively. About half of the studies reported precision (48.8%) and recall (53.7%). Few studies reported external validation 
performed (10.8%), data availability (8.5%) and code availability (9.1%). There was no pattern of performance associ‑
ated with the overall reporting quality.
Conclusions: There is a range of potential clinical applications for NLP of radiology reports in health services and 
research. However, we found suboptimal reporting quality that precludes comparison, reproducibility, and replication. 
Our results support the need for development of reporting standards specific to clinical NLP studies.
Keywords: Natural language processing, Radiology reports, Systematic review
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Background
Medical imaging reports, written by radiologists, contain 
rich data about patients’ health and disease which are 
not routinely captured in structured healthcare admin-
istrative datasets. Ready access to these data would be 
of great benefit for research and health-care quality 
improvement, particularly to examine the health of large 
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populations. However, this resource is currently underu-
tilised because manual extraction of data from free-text 
imaging reports is time-consuming. Natural language 
processing (NLP) is an automated technique used to ana-
lyse language (often in free-text) and convert it to a struc-
tured format that is easier to use; thus, NLP provides the 
means to retrieve granular information from imaging 
reports [1], by-passing the need for manual extraction, 
and simplifies research with these data.
Systematic review of the clinical NLP literature is 
important to identify promising developments, poten-
tial harms, and to help avoid duplication of effort; how-
ever, research synthesis in this area is complicated by a 
lack of consistency in study methods and reporting [2]. 
There are no clear reporting guidelines for clinical NLP 
studies, perhaps because NLP is used in so many differ-
ent study designs. Methods and reporting guidance for 
clinical trials using machine learning (ML) [3–5] have 
recently been published, and extended guidelines are also 
being developed for the reporting of predictive ML mod-
els [6, 7]. Structured reporting protocols have also been 
suggested for NLP in clinical outcomes research [8] and 
also codes of practice for the use of Artificial Intelligence 
(AI) in radiology [9]. However, publications which have 
evaluated the reporting standards of ML studies [6] and 
its sub-field, deep learning (DL) [10], in clinical settings 
have shown low reporting standards which make this 
research difficult to interpret, replicate, or synthesise. 
Whether clinical NLP in general has better reporting is 
unclear from existing reviews [11].
In this systematic review, we examine the quality of 
reporting of studies that apply clinical NLP to imaging 
reports. We chose imaging reports because they are rela-
tively accessible and of small size, with a restricted vocab-
ulary [12], which makes them suitable for NLP. We aimed 
to establish the current state of reporting of studies that 
apply NLP to imaging reports and to identify NLP-spe-
cific criteria to assist future reporting. An accompany-
ing informatics paper has been written which provides 
a more detailed overview of the NLP methods used and 
their clinical applications [13].
Methods
We published our review protocol (https:// doi. org/ 10. 
17504/ proto cols. io. bmwhk 7b6) [14] and this report 
follows the Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis (PRISMA) [15] guideline.
Search strategy
We designed an automated search of Google Scholar with 
’Publish or Perish’ software [16] to identify articles pub-
lished between January 2015 and October 2019, building 
on an existing review by Pons et al. [11] which included 
literature published up to October 2014 (details of the 
automated search can be found in Additional file 1). Our 
search was executed on 27th November 2019 and our 
search terms were: ("radiology" OR "radiologist") AND 
("natural language" OR "text mining" OR "information 
extraction" OR "document classification" OR "word2vec") 
NOT patent. We also used a snowballing method to con-
duct a citation search using a list of publications that cite 
the Pons et al. review [11] and the articles cited in Pons’ 
review [11]. The results of these two search approaches 
were combined [13].
Study selection
We first ran an automated screening of papers to remove 
any duplicates and irrelevant publications. The criteria 
used to filter out irrelevant publications were: language is 
not English; the word ’patent’ is found in the title or URL; 
year of publication before 2015, as our review aimed to 
update a previous review by Pons et al. (2016); the words 
’review’ or ’overview’ found in the title, or ’this review’ 
found in the abstract; image keywords found in the title 
or abstract with no NLP terminology in the abstract; and 
finding either no radiology keywords or no NLP termi-
nology in the title or abstract (more details can be found 
in Additional file 1).
Four reviewers (three NLP researchers [DD, AG, HD] 
and one epidemiologist [MTCP]) then screened all titles 
and abstracts for potentially eligible studies. All papers 
that two or more reviewers approved for inclusion pro-
gressed to full paper review, and papers only selected by 
one reviewer for inclusion were discussed by these four 
reviewers to achieve agreement on inclusion or exclu-
sion. Lastly, eight reviewers (six NLP researchers [AG, 
HD, VS, AC, BA, HW] and two epidemiologists [ED 
and MP]) carried out the full paper screening according 
to the inclusion and exclusion criteria specified below 
and resolved any uncertainties by group discussion. All 
papers were double reviewed by an NLP researcher.
Inclusion and exclusion criteria
We included studies that applied NLP to radiology 
reports of any imaging modality. Our exclusion crite-
ria were: (1) wrong publication type e.g. case reports, 
reviews, conference abstracts, comments, or editorials; 
(2) research not using radiology reports (e.g. using lab 
reports or clinical notes); (3) research using radiology 
images only (not using NLP methods); (4) not reporting 
any NLP results; (5) not available in full text; (6) dupli-
cates; (7) articles written in a language other than Eng-
lish; (8) published before 2015; and (9) patents. The last 
four criteria should have been pre-filtered out by the 
automatic screening but we maintained these criteria to 
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be consistent and exclude any papers that the filtering 
had missed.
Data extraction
The key data extracted were: year of publication, primary 
clinical application and primary technical objective, study 
period, language of radiology reports, anatomical region, 
imaging modality, disease area, size of data set, anno-
tated set size, training set size, validation set size, test set 
size, external validation performed, domain expert used, 
number of annotators, inter-annotator agreement, NLP 
technique(s) used, best reported results (recall, precision 
and F1 score), availability of data set, and availability of 
code.
Data categorisation
We categorised the primary clinical application of each 
study. ‘Clinical application’ was the reported health-
related purpose of the study. We iteratively developed 
a classification to represent the literature in our review, 
extending an existing categorisation [11], which ulti-
mately included the categories of diagnostic surveillance, 
disease information and classification, language discov-
ery and knowledge structure, quality and compliance, 
cohort and epidemiology, and technical NLP (Table 1).
Quality assessment
There are no reporting guidelines or risk of bias tools 
available specifically for clinical NLP studies. To address 
this issue, we specified 15 criteria which we considered 
would need to be reported to enable assessment of risk 
of bias and assist replication of these studies. We took 
account of both existing guidelines for epidemiological 
research [17] and also guidance emerging from the clini-
cal NLP community [3–9] when selecting these criteria, 
and sought group consensus on items that were generic 
measures of quality that would be readily applicable 
across the broad selection of methods included under 
clinical NLP. These criteria are described in detail in 
Table 2 and fall under the five headings of: data source, 
datasets, ground truth, outcomes, and reproducibility. 
Our choice of criteria may not encompass everything 
necessary to assess all NLP studies in radiology. For 
example, there may be additional outcomes metrics that 
need to be reported (other than precision and recall) 
depending on the NLP tasks and clinical applications. 
There also may be additional, more specific, measures 
that would further assist reproduction and allow com-
parison of the performance of particular types of NLP, 
such as hyperparameter selection for ML [18]. However, 
as we included a broad remit of research, across ML, DL 
and Rule Based systems, we were unable to include such 
granular measures specific to any particular method. 
However, our criteria represent core considerations 
identified to allow a consistent overview of the quality of 
studies across the heterogeneous body of research com-
prising clinical NLP and could be further developed for 
specific methods.
Assessment of performance
We did not summarise results quantitatively due to the 
anticipated methodological heterogeneity. Our approach 
was a narrative synthesis of studies and visual summari-
sation of NLP performance stratified by quality of report-
ing and clinical application categories. We categorised 
studies into high and low reporting quality groups by 
the median number of qualities achieved. For this analy-
sis, when a study reported precision and recall without 




Our search identified 4,836 publications of which 274 
were potentially eligible. After full eligibility assessment, 
we included 164 studies that used NLP on radiology 
reports (Fig. 1). Figure 2 presents the number of studies 
identified by year and illustrates the breakdown of studies 
by both clinical application category and NLP method. 
The number of publications increased from 22 in 2015 to 
55 in 2019 (up to October 2019). There were more stud-
ies using deep learning techniques more recently (Fig. 2). 
Table 1 attributes the studies to their clinical application 
categories and Table S1 (in Additional file 1) provides a 
detailed description of the study characteristics.
The most common clinical applications of these NLP 
studies were disease information or classification (28%) 
and diagnostic surveillance (27.4%), followed by language 
discovery and knowledge structure (16.5%), quality and 
compliance (12.2%) and then research (9.8%). Of the 
NLP methods used, rule-based alone (26%) and machine 
learning alone (24%) were most frequently applied. Deep 
learning methods alone were used in 16 studies (9.8%), 
rising from 0 in 2015 to 14 papers (25%) in 2019. More 
specifics of the NLP methods and clinical applications 
can be found in our accompanying informatics paper 
[13]. The majority (86%) of studies used English language 
radiology reports, with the other languages reported 
including Chinese, Spanish, German, French, Italian, 
Portuguese, Polish and Hebrew. The imaging modali-
ties reported were mixed (28%), computerised tomog-
raphy (23%), magnetic resonance imaging (9.8%), X-ray 
(4.9%), ultrasound (2.4%), mammography (3%), and other 
types (15%). The most frequent disease area was oncol-
ogy (24%) and images of mixed anatomical regions were 
most frequent (26.2%), followed by thorax (19.5%) and 
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head and neck (15.2%). The size of the datasets varied 
greatly between studies; eleven studies did not give data 
sizes; and others studies reported numbers of sentences, 
patients, or mixed data sources rather than numbers of 
reports. With these caveats, the median dataset size was 
3,032 (IQR 875, 70 000).
Reporting quality of included studies
Reporting of the pre-specified criteria varied across the 
included studies and years of publication (Fig. 3a, b). The 
median number of qualities achieved was 5. Consistent 
image acquisition was the most incompletely reported 
aspect of studies: 11 (6.7%) studies included informa-
tion on the number and type of imaging machines used 
and just eight of the 11 studies specified that images 
were of consistent quality where various sites and imag-
ing machines were used. Other criteria where incomplete 
reporting was particularly evident were reporting the 
results of external validation, only 15/139 (10.8%) studies; 
reporting of study data to make it available for external 
use, 14 (8.5%) studies; and the reporting of study code to 
make it available for external use, 15 (9.1%) studies.
The method for imaging reports sampling was also 
incompletely reported: 71 (43.3%) studies specified 
their sampling strategy, and only 33 (46.5%) of these 
studies sampled imaging reports consecutively. Most 
studies reported the size of their overall data set (93.3%) 
and 85.4% had a dataset size exceeding 200. However, 
the split of datasets in each study for training, valida-
tion, and test sets was reported only moderately well 
(63.4%, 45.7%, and 67.7% respectively). Annotated data-
sets were reported for 110 (67.1%) of the studies. Just 
under half of the studies (47.6%) reported the annota-
tor expertise and 70 (42.7%) confirmed it was a domain 
expert. The number of annotators was specified in 91 
(55.5%) studies and the inter-annotator agreement was 
reported for 67 (60.9%) of the 110 studies that used 
annotated data sets. We found that 80 (48.8%) and 88 
(53.7%) studies, respectively, reported the performance 
metrics of precision and recall for their applications. 
There was no apparent improvement in reporting on 
visual inspection (Fig. 3b).
Study performance
In looking at study performance we also examined the 
71 (43%) studies reporting F1 score. In studies report-
ing at least one of the performance measures (preci-
sion, recall and F1 score), there was no clear pattern 
of performance associated with quality of reporting or 
with stratification by clinical application (Fig. 4).
Table 2 Items used to assess the quality of reporting criteria in the current review
Quality heading Quality criteria Definition
Data source (1) Sampling Reported details of the sampling strategy for radiology reports, including whether they are 
from consecutive patients
(2) Consistent imaging acquisition Reported whether radiology reports were from images taken from one imaging machine 
or more and, if more, whether these machines were of comparable specification
Dataset criteria (3) Dataset size Reported their dataset size of > 200
(4) Training dataset Reported training data set size—the part of the initial dataset used to develop an NLP 
algorithm
(5) Test dataset Reported test data set size—part of the initial dataset used to evaluate an NLP algorithm
(6) Validation dataset Reported validation data set size—a separate dataset used to evaluate the performance of 
an NLP algorithm in a clinical setting (may be internal or external to the initial dataset)
Ground truth criteria (7) Annotated dataset Reported annotated data set size—data which has been marked‑up by humans for 
ground truth
(8) Domain expert for annotation Reported use of a domain expert for annotation—annotation carried out by a radiologist 
or specialist clinician
(9) Number of annotators Reported the number of annotators
(10) Inter‑annotator agreement Reported the agreement between annotators (if more than one annotator used)
Outcome criteria (11) Precision Reported precision (positive predictive value)
(12) Recall Reported recall (sensitivity)
Reproducibility criteria (13) External validation Reported whether the NLP algorithm is tested on external data from another setting (a 
separate healthcare system, hospital or institution)
(14) Availability of data Reported whether their data set is available for use (preferably with link provided in paper)
(15) Availability of NLP code Reported whether their NLP code is available for use (preferably with link provided in 
paper)
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Discussion
We conducted a systematic review of the quality 
of reporting of studies of NLP in radiology reports 
between 2015 and 2019. This review chronologically 
updated an existing review by Pons et al., although the 
focus of their review was on the clinical applications of 
NLP tools, NLP methods, and their performance, and 
did not assess quality of reporting. We found increased 
research output in the time period of our review, 
retrieving 164 relevant publications compared with 67 
for the preceding review which searched for all pub-
lications indexed up to October, 2014. In our review, 
as anticipated, the use of deep learning methods had 
increased, but we found that rule-based and tradi-
tional machine classifiers were still widely used. The 
main clinical applications reported in papers remained 
broadly similar between the reviews, although we found 
more papers that did not specify any health-related 
purpose and we categorised these as: ‘Technical NLP’ 
and ‘Disease information and classification’. Pons et al. 
reported that many NLP tools remained at a ‘proof-of-
concept’ stage and our study determined that this prob-
lem persists in the body of literature we retrieved.
The main focus of our work was on the reporting of 
clinical NLP studies and we found that this was gener-
ally poor (meaning under half of the included studies 
reported the criterion) for eight of our 15 pre-specified 
criteria. In particular, the three reproducibility crite-
ria were met by only 15, 14 and 15 studies for exter-
nal validation, availability of data and availability of 
Fig. 1 PRISMA flowchart outlining the study selection process [13]
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code respectively. Although this is an expanding field, 
with a growth in publications, we found that reporting 
remained inconsistent and incomplete between 2015 
and 2019.
Most studies reported dataset size. However, we found 
that more detailed information on data sampling was 
often omitted and that had implications for assessing 
bias in these studies. For example, not reporting whether 
imaging reports were sampled from consecutive patients 
and not detailing the demographics of study participants 
affected determination of selection bias and impacted on 
the generalisability of applications from one population 
to another. The dangers of utilising data from unrepre-
sentative populations, particularly to train ML applica-
tions, has been stressed [19, 20] and considerations of 
equity and how models may vary across different settings 
have begun to be incorporated in existing guidance for 
ML [2]. The split of datasets between training, test and 
validation sets was also inadequately reported: 45.5%, 
40.9% and 31.8% of studies published in 2015 reported 
these criteria respectively. However, these dataset cri-
teria did appear to improve over time: 74.5%, 78.2% and 
56.4% of studies published in 2019 reported these criteria 
respectively. Assessment of information bias was difficult 
Fig. 2 Distribution of studies by publication year and a clinical application, b NLP methods
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because of the lack of details about comparable imaging 
machines and details of any annotation, including the 
number of annotators and whether they were domain 
experts.
Second, as recognised in ML [6] and DL [10] research, 
most NLP algorithms were ‘private’ and had not been 
replicated by their developers in other settings. It is 
therefore uncertain whether these tools are transfer-
able between settings. External validation is difficult, 
because obtaining and accessing suitable alternate data-
sets on which to test NLP tools is not easy. There are few 
publicly available datasets and those which are avail-
able [21–24] may not be representative of the datasets 
researchers want to use or the populations for whom 
they are developing their tools. For example, clinical 
datasets available from the United States may not trans-
late to another healthcare systems. External validation 
of clinical NLP tools is important to establish whether 
they can be adopted for more widespread use and clinical 
implementation.
Thirdly, external validation can be facilitated by the 
sharing of code and data to replicate research, but we 
found code was not available from many studies [25]. 
There are multiple institutional factors, some particular 
to healthcare data, which influence disclosure including 
privacy considerations, inconsistency in decision-mak-
ing by regulatory bodies, liability concerns due to these 
technologies being viewed akin to medical devices, and 
lastly concerns over cybersecurity [26]. Additionally, 
NLP researchers may not have work capacity to support 
the use of their NLP systems when used externally. The 
development of bodies to facilitate health data research, 
such as Health Data Research UK (HDRUK) promises to 
address many of these factors [27], but they may remain 
a barrier for some time and, in the interim, encouraging 
direct collaboration between clinical NLP researchers 
working in similar areas may be the most efficient way 
to expedite external validation. There have been active 
steps taken by the NLP community towards improving 
reproducibility for ML in particular, including the devel-
opment and implementation of reproducibility checklists 
specific to ML, and this shift in practice may spread to 
encompass other areas of the clinical NLP research com-
munity [28].
Fourth, specifying a clinical application is important 
to demonstrate that the tool has meaningful clinical 
Fig. 3 Quality of reporting in a individual studies and b between 2015 and 2019. Legend: a Studies are arranged by the total number of qualities 
reported in the study from left to right in descending order. b Numbers indicate the percentage of studies in each year of publication reporting the 
corresponding quality
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relevance, and also because transferability of algorithms 
to different clinical tasks is not assured. Volmer et al. [2], 
recently proposed 20 questions concerning transparency, 
reproducibility, ethics, and effectiveness (TREE) for ML 
and AI research and their first question urges researchers 
from the inception of a project to stipulate the relevance 
of their work to healthcare and patients. This require-
ment is also born out in the CONSORT-AI reporting 
guidelines [4]. For our review, we generated six clinical 
application categories, extending Pons et  al.’s existing 
framework [11] and disaggregating them into underlying 
subcategories, and we discovered that many studies did 
not specify a clinical application. Our study taxonomy 
may be useful for other researchers wishing to identify 
existing work to build on or to identify clinical areas with 
gaps that remain unaddressed. In addition, our inclusion 
of more disaggregated clinical application subcategories 
(Table  1) could potentially facilitate future work to col-
late these applications within ‘like’ categories to examine 
their performance in carrying out similar clinical tasks.
Lastly, we summarized the performance of all 164 
studies and sought trends according to their qual-
ity of reporting and clinical application. However, no 
clear associations emerged. This is likely due to the 
Fig. 4 Precision, recall and F1 score by quality of reporting and clinical application category. Legend: NLP system performance reported as precision, 
recall and F1 score from included studies. Size of the bubbles represents the relative sizes of corpora in each graph. a Studies were categorised into 
high (> 5 qualities) and low (≤ 5 qualities) reporting quality based on the median number of qualities reported as the cut‑off point. Reporting of F1 
score was not a quality criterion. b Performance stratified by clinical application
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heterogeneity within clinical NLP studies and their con-
textual nature. The best performing methods for a clini-
cal NLP tool are likely determined by the intersection 
of multiple factors including clinical application, type of 
reports (including modality and indication), the specific 
information required (including rarity of conditions), 
the need for clinical input, the complexity of the NLP 
task being carried out, and the performance parameters 
required to be acceptable for clinical implementation and 
minimisation of harm.
The implications of our findings for practice are that, 
despite a large body of work and the potential advantages 
of NLP in clinical settings, advancing these tools to the 
stage of widespread implementation is hindered by poor 
standards of reporting, particularly relating to external 
validation and the sharing of NLP code and data. This 
reflects the situation reported for the sub-fields of ML 
and AI where systematic review identified that most 
studies failed to use or adhere to any existing reporting 
guidance [6, 10], and that data and code availability were 
lacking [10]. However, a move has begun to pursue trans-
parency and replicability within AI, ML and DL research 
[2], which all clinical NLP should follow, including initi-
ating the development of extended reporting guidelines 
[3, 4, 7]. Where no extended guidelines exist, we recom-
mend that researchers follow guidelines specific to study 
type [29] and also consider reporting the 15 NLP specific 
criteria which we have sought in our review.
Our review was strengthened by the large number, 
and wide variety, of studies identified. However, the het-
erogeneity of this literature was also a limitation in that 
it precluded any meta-analysis of outcomes. Limita-
tions of our review also included having developed our 
own quality assessment criteria, due to the lack of avail-
able tools in this field. We acknowledge that there may 
be additional criteria that could assist quality assessment 
either for specific types of NLP (such as hyperparameter 
selection for ML) or more generally; for example, includ-
ing a description of computing infrastructure could also 
assist assessment of reproducibility and could be readily 
shared [18]. We also did not exclude any studies based on 
poor quality. However, we feel that this approach is fitting 
for a review where meta-analysis is not undertaken and 
where we focus on demonstrating the breadth of work 
and assessing reporting quality across the whole body of 
work. Utilising an automated search in Google Scholar 
may have impeded our search sensitivity, although it 
has been shown to have very comprehensive coverage 
[30]. Our clinical application categories were also devel-
oped through this review process and there was overlap 
for some studies where decisions had to be made by the 
reviewers as to their primary application. These decisions 
were naturally subjective and studies could be reassigned, 
however decisions were discussed and agreed by at least 
two reviewers.
Conclusions and recommendations
Our systematic review of the use of NLP on radiology 
reports, for the period 2015–2019, found substantial 
growth in research activity, but no clear improvement in 
reporting of key data to allow reproducibility and repli-
cation. This impedes synthesis of this research field. In 
this paper we provide an overview of the current land-
scape and offer developments in both the categorisation 
of clinical applications for NLP on radiology reports and 
suggested criteria for inclusion in quality assessment of 
this research. This paper complements the limited guid-
ance which has been published to date in relation to AI in 
radiology [9], clinical NLP [8], and ML within NLP [2–5] 
and we hope that our criteria can contribute to develop-
ments for formally agreed standards specific to clinical 
NLP.
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